Bone Biologics Corporation (BBLG)
USD 0.86
(1.91%)
USD 0.86
(1.91%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 9.42 Million USD | 157.24% |
| 2022 | 3.66 Million USD | 232.75% |
| 2021 | 1.1 Million USD | 33.51% |
| 2020 | 825.01 Thousand USD | -66.29% |
| 2019 | 2.44 Million USD | -12.31% |
| 2018 | 2.79 Million USD | 6.26% |
| 2017 | 2.62 Million USD | -85.28% |
| 2016 | 17.84 Million USD | 48.79% |
| 2015 | 11.99 Million USD | 298.46% |
| 2014 | 3.01 Million USD | 348.02% |
| 2013 | 671.98 Thousand USD | 154143.87% |
| 2012 | 435.66 USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 100.0% |
| 2008 | -13.34 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 903.53 Thousand USD | -22.11% |
| 2024 Q2 | 809.66 Thousand USD | -10.39% |
| 2023 Q1 | 3.14 Million USD | 144.24% |
| 2023 Q4 | 1.16 Million USD | -44.25% |
| 2023 Q3 | 2.08 Million USD | -31.55% |
| 2023 FY | 9.42 Million USD | 157.24% |
| 2023 Q2 | 3.03 Million USD | -3.42% |
| 2022 Q4 | 1.28 Million USD | 5.69% |
| 2022 Q2 | 469.3 Thousand USD | -28.51% |
| 2022 Q1 | 656.42 Thousand USD | 43.05% |
| 2022 FY | 3.66 Million USD | 232.75% |
| 2022 Q3 | 1.21 Million USD | 159.81% |
| 2021 Q2 | 231.88 Thousand USD | 28.16% |
| 2021 Q3 | 229.78 Thousand USD | -0.9% |
| 2021 Q4 | 458.88 Thousand USD | 99.7% |
| 2021 FY | 1.1 Million USD | 33.51% |
| 2021 Q1 | 180.92 Thousand USD | -12.36% |
| 2020 Q2 | 132.7 Thousand USD | -60.97% |
| 2020 Q4 | 206.43 Thousand USD | 41.56% |
| 2020 FY | 825.01 Thousand USD | -66.29% |
| 2020 Q1 | 340.05 Thousand USD | 22.48% |
| 2020 Q3 | 145.82 Thousand USD | 9.88% |
| 2019 Q3 | 301.31 Thousand USD | -55.64% |
| 2019 Q2 | 679.25 Thousand USD | -42.88% |
| 2019 Q1 | 1.18 Million USD | -4.0% |
| 2019 FY | 2.44 Million USD | -12.31% |
| 2019 Q4 | 277.62 Thousand USD | -7.86% |
| 2018 Q3 | -404.79 Thousand USD | -147.06% |
| 2018 FY | 2.79 Million USD | 6.26% |
| 2018 Q4 | 1.23 Million USD | 406.04% |
| 2018 Q2 | 860.15 Thousand USD | -21.57% |
| 2018 Q1 | 1.09 Million USD | -16.32% |
| 2017 Q1 | 2.16 Million USD | -31.27% |
| 2017 FY | 2.62 Million USD | -85.28% |
| 2017 Q4 | 1.31 Million USD | 15.9% |
| 2017 Q3 | 1.13 Million USD | 157.26% |
| 2017 Q2 | -1.97 Million USD | -191.43% |
| 2016 Q2 | 4.28 Million USD | -34.63% |
| 2016 FY | 17.84 Million USD | 48.79% |
| 2016 Q4 | 3.14 Million USD | -18.52% |
| 2016 Q1 | 6.56 Million USD | -13.61% |
| 2016 Q3 | 3.85 Million USD | -10.05% |
| 2015 Q4 | 7.59 Million USD | 155.81% |
| 2015 Q3 | 2.96 Million USD | 481.39% |
| 2015 Q2 | 510.57 Thousand USD | -44.71% |
| 2015 Q1 | 923.42 Thousand USD | 17.49% |
| 2015 FY | 11.99 Million USD | 298.46% |
| 2014 Q4 | 785.96 Thousand USD | -54.68% |
| 2014 FY | 3.01 Million USD | 348.02% |
| 2014 Q3 | 1.73 Million USD | 434.26% |
| 2014 Q2 | 324.63 Thousand USD | 85.24% |
| 2014 Q1 | 175.24 Thousand USD | -27.18% |
| 2013 FY | 671.98 Thousand USD | 154143.87% |
| 2013 Q3 | 119.18 Thousand USD | -43.61% |
| 2013 Q2 | 211.37 Thousand USD | 35.43% |
| 2013 Q4 | 240.64 Thousand USD | 101.9% |
| 2013 Q1 | 156.07 Thousand USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | 435.66 USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 100.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | -13.34 Thousand USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | 15.999% |
| Cerus Corporation | 143.15 Million USD | 93.414% |
| OrthoPediatrics Corp. | 137.01 Million USD | 93.119% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 17.011% |
| Talis Biomedical Corporation | 67.18 Million USD | 85.967% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 62.205% |
| Inogen, Inc. | 236.08 Million USD | 96.006% |
| Spectral AI, Inc. | 20.86 Million USD | 54.811% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 83.163% |
| CVRx, Inc. | 76.14 Million USD | 87.617% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -167.242% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 24.507% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.587% |
| Venus Concept Inc. | 80.47 Million USD | 88.284% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 83.336% |
| Bioventus Inc. | 409.91 Million USD | 97.7% |
| BrainsWay Ltd. | 28.01 Million USD | 66.349% |
| Envoy Medical, Inc. | 17.89 Million USD | 47.322% |
| electroCore, Inc. | 32.03 Million USD | 70.565% |
| IceCure Medical Ltd | 16.87 Million USD | 44.132% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 77.78% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 46.53% |
| MaxCyte, Inc. | 84.84 Million USD | 88.888% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 24.037% |
| Nexalin Technology, Inc. | 5.78 Million USD | -63.081% |
| PAVmed Inc | 64.82 Million USD | 85.456% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 81.541% |
| RxSight, Inc. | 103.85 Million USD | 90.921% |
| Sight Sciences, Inc. | 126.44 Million USD | 92.544% |
| SI-BONE, Inc. | 156.35 Million USD | 93.97% |
| TELA Bio, Inc. | 84.18 Million USD | 88.801% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 86.542% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 95.364% |
| LivaNova PLC | 843.54 Million USD | 98.882% |
| 908 Devices Inc. | 68.08 Million USD | 86.151% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 98.05% |
| Nemaura Medical Inc. | 7.13 Million USD | -32.071% |
| NeuroPace, Inc. | 75.29 Million USD | 87.478% |
| LENSAR, Inc. | 33.33 Million USD | 71.717% |
| Apyx Medical Corporation | 51.01 Million USD | 81.52% |
| Cutera, Inc. | 197.72 Million USD | 95.232% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 61.954% |
| BioSig Technologies, Inc. | 28.53 Million USD | 66.953% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 95.076% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 73.854% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.873% |
| Axonics, Inc. | 270.2 Million USD | 96.511% |
| Outset Medical, Inc. | 198.77 Million USD | 95.257% |
| IRIDEX Corporation | 31.81 Million USD | 70.364% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 94.768% |
| IRadimed Corporation | 30.12 Million USD | 68.7% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -10.505% |
| INVO Bioscience, Inc. | 7.85 Million USD | -20.055% |
| Telesis Bio, Inc. | 63.48 Million USD | 85.15% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 90.424% |
| Varex Imaging Corporation | 224.8 Million USD | 95.806% |
| Quipt Home Medical Corp. | 148.66 Million USD | 93.658% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 19.574% |
| Pulmonx Corporation | 112.68 Million USD | 91.633% |
| Dynatronics Corporation | 9.9 Million USD | 4.842% |
| Modular Medical, Inc. | 17.52 Million USD | 46.213% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 53.295% |
| Semler Scientific, Inc. | 38.94 Million USD | 75.79% |
| InMode Ltd. | 215.68 Million USD | 95.629% |
| Bruker Corporation | 1.07 Billion USD | 99.124% |
| Cytosorbents Corporation | 48.33 Million USD | 80.495% |
| DexCom, Inc. | 1.69 Billion USD | 99.443% |
| Align Technology, Inc. | 2.07 Billion USD | 99.546% |
| Viveve Medical, Inc. | 22.17 Million USD | 57.478% |
| ZimVie Inc. | 275.12 Million USD | 96.573% |
| Movano Inc. | 29.69 Million USD | 68.244% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 93.132% |
| Nexalin Technology, Inc. | 5.78 Million USD | -63.081% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -167.242% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 98.431% |
| Profound Medical Corp. | 33.6 Million USD | 71.942% |
| Insulet Corporation | 939.9 Million USD | 98.997% |
| enVVeno Medical Corporation | 25.23 Million USD | 62.642% |
| Surmodics, Inc. | 98.69 Million USD | 90.447% |
| iCAD, Inc. | 22.22 Million USD | 57.578% |
| Nuwellis, Inc. | 22.61 Million USD | 58.306% |
| Biotricity, Inc. | 17.18 Million USD | 45.135% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 97.886% |
| Aethlon Medical, Inc. | 12.27 Million USD | 23.207% |
| InspireMD, Inc. | 22.95 Million USD | 58.918% |
| PAVmed Inc. | 64.82 Million USD | 85.456% |
| BIOLASE, Inc. | 34.66 Million USD | 72.799% |
| Beyond Air, Inc. | 61.7 Million USD | 84.719% |
| FONAR Corporation | 28.6 Million USD | 67.039% |
| AxoGen, Inc. | 149.33 Million USD | 93.687% |
| Vivani Medical, Inc. | 26.96 Million USD | 65.035% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 94.676% |
| Inari Medical, Inc. | 448.59 Million USD | 97.898% |
| UFP Technologies, Inc. | 58.08 Million USD | 83.769% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -91.337% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -49.222% |
| Tenon Medical, Inc. | 16.96 Million USD | 44.435% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -27.53% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 78.622% |
| AdaptHealth Corp. | 1.07 Billion USD | 99.125% |
| Sintx Technologies, Inc. | 15.2 Million USD | 37.976% |
| NanoVibronix, Inc. | 4.97 Million USD | -89.59% |
| Quanterix Corporation | 118.1 Million USD | 92.017% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 19.574% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 34.716% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 97.599% |
| TransMedics Group, Inc. | 182.82 Million USD | 94.843% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 66.405% |
| NeuroMetrix, Inc. | 11.09 Million USD | 15.052% |
| Hyperfine, Inc. | 52.87 Million USD | 82.168% |
| Establishment Labs Holdings Inc. | 172 Million USD | 94.519% |
| Biomerica, Inc. | 6.97 Million USD | -35.115% |
| AVITA Medical, Inc. | 80.77 Million USD | 88.328% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | 8.563% |
| Silk Road Medical, Inc | 186.35 Million USD | 94.941% |